![<?echo $_SERVER['SERVER_NAME'];?>](/template/twentyseventeen/skin/images/header.jpg)
The reporter learned from the Shanghai Liver Disease and Liver Transplant Forum held recently that living liver transplants in China have developed rapidly in the past two years. As of March this year, China has completed 643 cases of living liver transplantation, of which 406 cases were implemented in 2007. The Department of Organ Transplantation at Shanghai Renji Hospital has successfully completed 120 cases of living donor liver transplantation, especially infant and child living donor liver transplantation. The breakthrough has been achieved. 14 cases of congenital biliary atresia infants and young children living liver transplantation have been completed. Success rate, success rate Up to 93% provides a new path for children with congenital biliary atresia.
The first case of a living donor liver transplantation was 4 years old, and there was no difference in growth, development, medical indicators and living conditions from normal infants. According to Xia Qiang, director of the transplantation department at Shanghai Renji Hospital, living donor livers are currently the most effective way to expand the source of donor livers as donors become increasingly scarce.
At the forum, the concept of "precision liver resection" also attracted the attention of experts. It is understood that the difference and advantage of precision hepatectomy and traditional hepatectomy is that it requires precise imaging before surgery to guide the anatomical approach to liver incision, and accurate determination of liver reserve function, accurate judgment of the remaining liver volume, without blocking Hepatic blood flow or only need to selectively block the blood flow of the liver section or segment to be resected, and more importantly, the surgeon must be skilled in using ultrasonic scalpels or water jets to acquire sufficient surgical skills.
Experts said that with the further development of the minimally invasive surgery concept in liver surgery, as well as imaging technology improvement and the development of 3D technology, the concept of "precision hepatectomy" has been proposed and clinical practice has resulted in the invasion of huge hepatocellular carcinoma with portal vein and hepatic veins. Hepatic hemangioma, multiple metastatic hepatic metastases, and complex hilar cholangiocarcinoma have provided new hope for patients who were previously thought to have low surgical resection rates or who are at high risk for surgery.
The first case of a living donor liver transplantation was 4 years old, and there was no difference in growth, development, medical indicators and living conditions from normal infants. According to Xia Qiang, director of the transplantation department at Shanghai Renji Hospital, living donor livers are currently the most effective way to expand the source of donor livers as donors become increasingly scarce.
At the forum, the concept of "precision liver resection" also attracted the attention of experts. It is understood that the difference and advantage of precision hepatectomy and traditional hepatectomy is that it requires precise imaging before surgery to guide the anatomical approach to liver incision, and accurate determination of liver reserve function, accurate judgment of the remaining liver volume, without blocking Hepatic blood flow or only need to selectively block the blood flow of the liver section or segment to be resected, and more importantly, the surgeon must be skilled in using ultrasonic scalpels or water jets to acquire sufficient surgical skills.
Experts said that with the further development of the minimally invasive surgery concept in liver surgery, as well as imaging technology improvement and the development of 3D technology, the concept of "precision hepatectomy" has been proposed and clinical practice has resulted in the invasion of huge hepatocellular carcinoma with portal vein and hepatic veins. Hepatic hemangioma, multiple metastatic hepatic metastases, and complex hilar cholangiocarcinoma have provided new hope for patients who were previously thought to have low surgical resection rates or who are at high risk for surgery.